205
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Tissue-Selective Regulation of Androgen-Responsive Genes

, &
Pages 203-215 | Published online: 16 May 2012

REFERENCES

  • Brinkmann AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol 2001;179(1–2):105–109.
  • Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS, Hess RA. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl 2002;23(6):870–881.
  • Holzbeierlein JM, McLaughlin MD, Thrasher JB. Complications of androgen deprivation therapy for prostate cancer. Curr Opin Urol 2004;14(3):177–183.
  • Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 2004;89(10):5245–5255.
  • Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocrine Rev 2004;25(3):389–425.
  • Singh R, Artaza JN, Taylor WE, . Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006;147(1):141–154.
  • Lieberburg I, MacLusky N, McEwen BS. Androgen receptors in the perinatal rat brain. Brain Res 1980;196(1):125–138.
  • Shah NM, Pisapia DJ, Maniatis S, Mendelsohn MM, Nemes A, Axel R. Visualizing sexual dimorphism in the brain. Neuron 2004;43(3):313–319.
  • Taylor LG, Canfield SE, Du XL. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 2009;115(11):2388–2399.
  • Alsantali A, Shapiro J. Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes 2009;16(3):246–253.
  • Park SY, Kwack MH, Chung EJ, . Establishment of SV40T-transformed human dermal papilla cells and identification of dihydrotestosterone-regulated genes by cDNA microarray. J Dermatol Sci 2007;47(3):201–208.
  • Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91(1):48–53.
  • Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A. Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev 2009;(1):CD005997.
  • Gonzalez LO, Corte MD, Vazquez J, . Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer 2008;8:149.
  • Keller ET, Ershler WB, Chang C. The androgen receptor: a mediator of diverse responses. Front Biosci 1996:1:d59–d71.
  • Jones JO. Improving selective androgen receptor modulator discovery and preclinical evaluation (review). Expert Opin Drug Discov 2009;4(9):981–993.
  • Tostain JL, Blanc F. Testosterone deficiency: a common, unrecognized syndrome. Nat Clin Pract Urol 2008;5(7):388–396.
  • Sprenkle PC, Fisch H. Pathologic effects of testosterone deprivation. Curr Opin Urol 2007;17(6):424–430.
  • Pucci E, Petraglia F. Treatment of androgen excess in females: yesterday, today and tomorrow. Gynecol Endocrinol 1997;11(6):411–433.
  • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010;60(5):277–300.
  • Mostaghel EA, Montgomery B, Nelson PS. Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease. Urol Oncol 2009;27(3):251–257.
  • Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19(2):185–193.
  • Dennis G Jr., Sherman BT, Hosack DA, . DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4(5):P3.
  • Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, . Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995;45(5):486–490.
  • Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65–70.
  • Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3: Article3.
  • Gentleman RC, Carey VJ, Bates DM, . Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5(10):R80.
  • Wang XD, Wang BE, Soriano R, . Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. Differentiation 2007;75(3):219–234.
  • Ivanga M, Labrie Y, Calvo E, . Fine temporal analysis of DHT transcriptional modulation of the ATM/Gadd45g signaling pathways in the mouse uterus. Mol Reprod Dev 2009;76(3):278–288.
  • Zhang Y, Calvo E, Martel C, Luu-The V, Labrie F, Tchernof A. Response of the adipose tissue transcriptome to dihydrotestosterone in mice. Physiol Genomics 2008;35(3):254–261.
  • Xu C, Graf LF, Fazli L, . Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression. Prostate 2007;67(15):1621–1629.
  • Zhou Q, Shima JE, Nie R, Friel PJ, Griswold MD. Androgen-regulated transcripts in the neonatal mouse testis as determined through microarray analysis. Biol Reprod 2005;72(4):1010–1019.
  • Nantermet PV, Xu J, Yu Y, . Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 2004;279(2):1310–1322.
  • Nantermet PV, Masarachia P, Gentile MA, . Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways. Endocrinology 2005;146(2):564–578.
  • Drummond ES, Harvey AR, Martins RN. Androgens and Alzheimer’s disease. Curr Opin Endocrinol Diabetes Obes 2009;16(3):254–259.
  • van Helden YG, Godschalk RW, Heil SG, . Downregulation of Fzd6 and Cthrc1 and upregulation of olfactory receptors and protocadherins by dietary beta-carotene in lungs of Bcmo1-/-mice. Carcinogenesis 2010;31(8):1329–1337.
  • Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 1999;21(5):426–431.
  • Trueb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002;37(8–9):981–990.
  • Gentile MA, Nantermet PV, Vogel RL, . Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin. J Mol Endocrinol 2010;44(1):55–73.
  • Treister NS, Richards SM, Rowley P, Jensen RV, Sullivan DA. Influence of testosterone on gene expression in the ovariectomized mouse submandibular gland. Eur J Oral Sci 2006;114(4):328–336.
  • Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal 2008;6:e010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.